Department of Urology, Seoul National University Bundang Hospital, 166, Gumi-ro, Bundang-gu, Seongnam, Gyeonggi-do, 463-707, South Korea.
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.
Urolithiasis. 2020 Apr;48(2):151-158. doi: 10.1007/s00240-019-01126-0. Epub 2019 Mar 14.
To investigate and compare surgical outcomes in totally tubeless percutaneous nephrolithotomy (ttPCNL) patients according to the type of sealant during nephrostomy tract closure, the records of 158 patients who underwent ttPCNL were retrospectively reviewed. Fibrin sealant [Tisseel; n = 107, fibrin-only sealant (FS)] or gelatin matrix hemostatic sealant [FloSeal; n = 51, gelatin matrix sealant (GS)] was applied during tract closure according to surgeon's preference. On the first postoperative day, computed tomography (CT) was scanned for all patients. Unsatisfactory radiological outcome (URO) was defined as any postoperative hematoma or urinoma (≥ 2 cm) on the CT. Unsatisfactory clinical outcome (UCO) was defined as any adverse event requiring additional intervention. Both UROs and UCOs were sub-classified as either hemorrhage or drainage related. 2:1 propensity score matching was applied according to clinical parameters. Median age was 58 (19-78) years and a mean stone size was 2.1 ± 1.1 cm. The treatment success rate (stone free or < 4 mm residual) among all patients was 91.1% (144/158). UROs and UCOs occurred in 35.4% (86/158) and 11.4% (18/158) of all cases, respectively. Neither of the frequency of URO nor hemorrhage-related UCO was different according to sealant type. However, drainage-related UCOs were more prevalent among the GS group, mainly due to the higher postoperative ureter stenting rate. The postoperative pain severity and the length of hospitalization were comparable between groups. In summary, using GS rather than FS during tract closure did not worsen hemorrhage-related outcomes. However, the clinical risk of ureter occlusion requiring additional temporary ureteral stenting was increased.
为了研究和比较经皮肾镜碎石取石术(PCNL)中不同封合剂在无管化经皮肾造瘘术(ttPCNL)中的手术效果,我们回顾性分析了 158 例接受 ttPCNL 患者的临床资料。根据术者的偏好,在经皮肾造瘘管关闭时应用纤维蛋白胶(Tisseel;n=107,纤维蛋白封合剂[FS])或明胶基质止血封合剂(FloSeal;n=51,明胶基质封合剂[GS])。所有患者术后第 1 天行 CT 扫描。将术后 CT 上发现的任何血肿或尿囊肿(≥2cm)定义为影像学结果不满意(URO)。将任何需要额外干预的不良事件定义为临床结果不满意(UCO)。URO 和 UCO 均分为与出血或引流相关的。根据临床参数进行了 2:1 倾向评分匹配。中位年龄为 58(19-78)岁,结石平均大小为 2.1±1.1cm。所有患者的治疗成功率(结石清除或<4mm 残留)为 91.1%(144/158)。URO 和 UCO 分别发生在所有病例的 35.4%(86/158)和 11.4%(18/158)。两种封合剂的 URO 发生率和出血相关 UCO 发生率均无差异。然而,GS 组引流相关 UCO 更为常见,主要是由于术后输尿管支架留置率较高。两组术后疼痛严重程度和住院时间相似。总之,在经皮肾造瘘管关闭时使用 GS 而不是 FS 不会加重出血相关结果。然而,需要额外临时输尿管支架置入以治疗输尿管闭塞的临床风险增加。